Survive and Thrive Boa Vista Early Childhood Program (STBV)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03386747 |
|
Recruitment Status : Unknown
Verified December 2017 by Alexandra Brentani, University of Sao Paulo.
Recruitment status was: Enrolling by invitation
First Posted : December 29, 2017
Last Update Posted : December 29, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Neonatal Death Mental Competency | Behavioral: Home visits to improve parenting behaviors Behavioral: Center based parenting groups | Not Applicable |
Even though much progress has been achieved in child mortality globally, relatively minor improvements have been realized in the first four weeks of children's life generally referred to as the neonatal period. Each year, four million infants die within the first 28 days of their life globally. As pointed out in the Lancet's neonatal survival series, 3 million neonatal deaths could be prevented each year by low-cost interventions. In Brazil, more than 25,000 newborns die each year within the first 28 days of their life, with a majority of deaths occurring in the first week. Previous studies suggest that one of the most effective ways to prevent such deaths are home visiting programs, which support mothers in the first weeks of infant's lives, promote breastfeeding and kangaroo mother care, and ensure appropriate medical care when needed. From a child health and child development perspective, optimal outcomes appear only feasible if continued support is provided to mothers from pregnancy throughout the first years of children's life. Home-based visits and support have become increasingly recognized as a both crucial and highly cost-effective strategy to achieve such outcomes.
The objective of this project is to extend and scale up the previously tested and validated home visiting programs to the city of Boa Vista. At the core of this program is a detailed curriculum, which contains gestation and age-specific topics of child health and development to be discussed with caregivers at each home visit. The intervention package will start in the third trimester of pregnancy and feature to sessions per month up to age 3 years.
This curriculum will be delivered through two separate - and randomly assigned - platforms: home visits through trained Child Development Agents (CDAs), and center-based delivery of the same delivery to groups of caregivers. The pilot study in Sao Paulo suggests that each CDA can handle approximately 40 families, visiting each caregiver twice per month. Visits will be initiated during the second trimester of pregnancy. The visits during pregnancy will not be a substitute for prenatal care but are designed to prepare mothers for babies and set up a relationship for a closer follow-up after birth. In Brazil, as well as globally, the numbers of pre-term deliveries and stillbirth is rather large, 20% of mature stillbirths (more than 37 weeks of gestation, more than 2.5 Kg) so the pre-natal care can be improved clearly. The visits would also occur during the neonatal period, when the largest proportional of under 5 mortality happens. This would be the first component of the program, addressing maternal and perinatal/neonatal mortality. Particular attention will be given to mothers after birth, with two special visits scheduled for the first week after birth focusing on maternal mental health; breastfeeding as well as kangaroo mother care when appropriate. Such visitation programs have been successfully tested within the family health strategy, and will be further reinforced and complemented by the new visitation program.
The city of Boa Vista has a population of approximately 330,000 people, with, 22,377 families (~30%) currently receiving social cash transfers under the bolsa familia program. The city is comparable to the national average in terms of the observed poverty rates, and roughly average in terms of its size. Infant mortality rate is estimated at 14.2 per 1000 live births, with 21% of births given by teenage mothers and 15% of infants born preterm.
The proposed project will exclusively target the most vulnerable households currently supported by the bolsa familia social cash transfer program. According to municipality estimates, about 5000 children are born each year in eligible households.
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 15000 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Masking Description: | Treatment requires active participation and will be revealed immediately. |
| Primary Purpose: | Health Services Research |
| Official Title: | Survive and Thrive in Brazil: Boa Vista Early Childhood Program |
| Actual Study Start Date : | December 1, 2017 |
| Estimated Primary Completion Date : | December 1, 2019 |
| Estimated Study Completion Date : | December 1, 2020 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Home Visiting Group
Intervention: Home visits to improve parenting behaviors
|
Behavioral: Home visits to improve parenting behaviors
Caregivers will be visited twice per month starting from the third trimester in pregnancy up to age three to discuss important health and development behaviors. |
|
Experimental: Center based parenting group
Intervention: Center based parenting groups
|
Behavioral: Center based parenting groups
Caregivers will be invited to early childhood development groups. Groups will meet at nearby centers twice per month. Caregivers will be invited to participate starting from the third trimester up to age 3 of the child. |
|
No Intervention: control group
The rest of pregnant women and their children who will not receive the intervention
|
- Overall child development - PRIDI score [ Time Frame: Age 2 - year 3 of the study ]Children's overall development will be assessed using the PRIDI child development assessment tool.
- Neonatal mortality [ Time Frame: 3 years ]Probability of death between day 0 and day 27 after birth
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | Child, Adult, Older Adult |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- pregnant women living in the urban area of Boa Vista
at LEAST ONE of the following vulnerability criteria
- bolsa família or other social cash transfer program recipient
- household income per capita less than half of minimum wage
- previous exposure to domestic or sexual violence before.
Exclusion Criteria:
- women living outside of Boa Vista urban area
- women not meeting social vulnerability criteria above
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03386747
| Brazil | |
| Faculdade de Medicina da Universidade de São Paulo | |
| São Paulo, SP, Brazil, 01246903 | |
| Principal Investigator: | Alexandra Brentani, PhD | University of São Paulo |
| Responsible Party: | Alexandra Brentani, Professor, University of Sao Paulo |
| ClinicalTrials.gov Identifier: | NCT03386747 |
| Other Study ID Numbers: |
TTS180818280 |
| First Posted: | December 29, 2017 Key Record Dates |
| Last Update Posted: | December 29, 2017 |
| Last Verified: | December 2017 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
child development neonatal mortality |
|
Perinatal Death Pregnancy Complications Death Pathologic Processes |

